GSK pulls bid to extend use of kidney drug to ovarian cancer
LONDON (Reuters) - GlaxoSmithKline on Monday withdrew an application to use Votrient, a drug licensed for kidney cancer, to treat advanced ovarian can...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/TUbGLXjmD3A/story01.htm
No comments:
Post a Comment